Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 175,174 - -
Change - -20.69% -0.18% 2.67% 11.05% -19.59% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 198,556 190,918 187,115
Change - -20.41% 0.28% 1.92% 9.66% -10.67% -3.85% -1.99%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 28.5x 22x 19.5x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.85x 3.44x 3.24x
PEG - -36.9x -2x 0x -0.7x -5.61x 0.8x 1.5x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.48x 3.2x 2.99x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.95x 3.49x 3.19x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 15.3x 13.2x 11.8x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 16.9x 14.7x 13.1x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 25x 20.4x 18.3x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 3.99% 4.9% 5.46%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.587 2.721 2.858
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.57% 2.71% 2.84%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.531 4.565 5.166
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 73.3% 59.6% 55.3%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,291 54,671 58,642
EBITDA 1 12,815 12,485 10,188 10,635 11,735 12,939 14,441 15,804
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,715 13,022 14,321
Net income 1 7,071 6,933 5,723 13,402 6,524 6,341 8,002 9,004
Net Debt 1 7,801 6,891 7,783 6,509 4,407 23,381 15,744 11,941
Reference price 2 140.74 109.79 110.07 113.11 125.29 100.57 100.57 100.57
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 26/1/22 25/1/23 24/1/24 22/1/25 22/1/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
28.06x3.95x15.35x2.57% 175B
18.58x3.26x11.47x3.63% 105B
16.72x0.19x11.83x0.79% 58.48B
31.6x7.68x20.06x1.27% 51.36B
38.16x3.06x10.42x2.51% 42.2B
35.64x1.32x11.59x0.28% 31.44B
29.18x5.19x16.57x-.--% 27.56B
42.59x7.45x26.87x0.24% 25.32B
23.19x3.39x12.2x1.25% 20.52B
19.4x2.68x10.44x1.62% 19.89B
Average 28.31x 3.82x 14.68x 1.42% 55.68B
Weighted average by Cap. 26.83x 3.71x 14.39x 2.01%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. Valuation Abbott Laboratories